Author Correction: Global dietary quality in 185 countries from 1990 to 2018 show wide differences by nation, age, education, and urbanicity (Nature Food, (2022), 3, 9, (694-702), 10.1038/s43016-022-00594-9)
Miller, V; Webb, P; Cudhea, F; Shi, P; Zhang, J; Reedy, J; Erndt-Marino, J; Coates, J; Mozaffarian, D; Bas, M; Ali, J H; Abumweis, S; Krishnan, A; Misra, P; Hwalla, N C; Janakiram, C; Liputo, N I; Musaiger, A; Pourfarzi, F; Alam, I; DeRidder, K; Termote, C; Memon, A; Turrini, A; Lupotto, E; Piccinelli, R; Sette, S; Anzid, K; Vossenaar, M; Mazumdar, P; Rached, I; Rovirosa, A; Zapata, M E; Asayehu, T T; Oduor, F; Boedecker, J; Aluso, L; Ortiz-Ulloa, J; Meenakshi, J V; Castro, M; Grosso, G; Waskiewicz, A; Khan, U S; Thanopoulou, A; Malekzadeh, R; Calleja, N; Ocke, M; Etemad, Z; Nsour, M A; Waswa, L M; Nurk, E; Arsenault, J; Lopez-Jaramillo, P; Sibai, A M; Damasceno, A; Arambepola, C; Lopes, C; Severo, M; Lunet, N; Torres, D; Tapanainen, H; Lindstrom, J; Virtanen, S; Palacios, C; Roos, E; Agdeppa, I A; Desnacido, J; Capanzana, M; Misra, A; Khouw, I; Ng, S A; Delgado, E G; Caballero, M; Otero, J; Lee, H -J; Koksal, E; Guessous, I; Lachat, C; De, Henauw S; Rahbar, A R; Tedstone, A; Naska, A; Mathee, A; Ling, A; Tedla, B; Hopping, B; Ginnela, B; Leclercq, C; Duante, C; Haerpfer, C; Hotz, C; Pitsavos, C; Rehm, C; van, Oosterhout C; Cerdena, C; Bradshaw, D; Trichopoulos, D; Gauci, D; Fernando, D; Sygnowska, E; Vartiainen, E; Farzadfar, F; Zajkas, G; Swan, G; Ma, G; Pekcan, G; Ibrahim, H M; Sinkko, H; Barbieri, H E; Sioen, I; Myhre, J; Gaspoz, J -M; Odenkirk, J; Bundhamcharoen, K; Nelis, K; Zarina, K; Biro, L; Johansson, L; Steingrimsdottir, L; Riley, L; Yap, M; Inoue, M; Szabo, M; Ovaskainen, M -L; Lee, M -S; Chan, M F; Cowan, M; Kandiah, M; Kally, O; Jonsdottir, O; Palmer, P; Vollenweider, P; Orfanos, P; Asciak, R; Templeton, R; Don, R; Yaakub, R; Selamat, R; Yusof, S; Al-Zenki, S; Hung, S -Y; Beer-Borst, S; Wu, S; Lukito, W; Hadden, W; Becker, W; Cao, X; Ma, Y; Lai, Y; Hjdaud, Z; Garriguet, D; Ali, J; Gravel, R; Tao, T; Veerman, J L; Chiplonkar, S; Arici, M; Ngoan, L T; Panagiotakos, D; Li, Y; Trichopoulou, A; Barengo, N; Khadilkar, A; Ekbote, V; Mohammadifard, N; Kovalskys, I; Laxmaiah, A; Rachakulla, H; Rajkumar, H; Meshram, I; Avula, L; Arlappa, N; Hemalatha, R; lacoviello, L; Bonaccio, M; Costanzo, S; Martin-Prevel, Y; Castetbon, K; Jitnarin, N; Hsieh, Y -T; Olivares, S; Tejeda, G; Hadziomeragic, A; de, Moura Souza A; Pan, W -H; Huybrechts, I; de, Brauw A; Moursi, M; Maghroun, M; Zeba, A N; Sarrafzadegan, N; Keinan-Boker, L; Goldsmith, R; Shimony, T; Jordan, I; Mastiholi, S C; Mwangi, M; Kombe, Y; Bukania, Z; Alissa, E; Al-Daghri, N; Sabico, S; Gulliford, M; Diba, T S; Oh, K; Kweon, S; Park, S; Cho, Y; Al-Hooti, S; Luangphaxay, C; Douangvichit, D; Siengsounthone, L; Marques-Vidal, P; Rybak, C; Luke, A; Rojroongwasinkul, N; Piaseu, N; Sundram, K; Baykova, D; Abedi, P; Fadzil, F; Bukhary, N B I; Bovet, P; Sandjaja, S; Chen, Y; Sawada, N; Tsugane, S; Rangelova, L; Petrova, S; Duleva, V; Lindroos, A K; Sipinen, J P; Moraeus, L; Bergman, P; Siamusantu, W; Szponar, L; Chang, H -Y; Sekiyama, M; Nagalla, B; Polasa, K; Boindala, S; Le, Nguyen Bao K; El, Ati J; Illescas-Zarate, D; Sanchez-Romero, L M; Silva, I R; Dommarco, J R; Barquera, S; Rodriguez-Ramirez, S; Ikeda, N; Zaghloul, S; Houshiar-rad, A; Mohammadi-Nasrabadi, F; Abdollahi, M; Chuah, K -A; Mahdy, Z A; Eldridge, A; Ding, E L; Kruger, H; Henjum, S; Fernandez, A; Suarez-Ortegon, M F; Al-Hamad, N; Janska, V; Tayyem, R; Mirmiran, P; Kelishadi, R; Lemming, E W; Richter, A; Mensink, G; Wieler, L; Hoffman, D; Salanave, B; Kim, C -I; Kuriyan-Raj, R; Swaminathan, S; Dastgiri, S; Vaask, S; Karupaiah, T; Zohoori, F V; Esteghamati, A; Noshad, S; Hashemian, M; Mwaniki, E; Yakes-Jimenez, E; Chileshe, J; Mwanza, S; Marques, L L; Preston, A M; Aguero, S D; Oleas, M; Posada, L; Ochoa, A; Shamsuddin, K; Shariff, Z M; Jan, Bin Jan Mohamed H; Manan, W; Nicolau, A; Tudorie, C; Poh, B K; Abbott, P; Pakseresht, M; Sharma, S; Strand, T; Alexy, U; Nothlings, U; Jan, Carmikle; Brown, K; Koster, J; Waidyatilaka, I; Lanerolle, P; Jayawardena, R; Long, J M; Hambidge, K M; Krebs, N F; Haque, A; Keding, G B; Korkalo, L; Erkkola, M; Freese, R; Eleraky, L; Stuetz, W; Thorsdottir, I; Gunnarsdottir, I; Serra-Majem, L; Moy, F M; Anderson, S; Jeewon, R; Zugravu, C A; Adair, L; Ng, S W; Skeaff, S; Marchioni, D; Fisberg, R; Henry, C; Ersino, G; Zello, G; Meyer, A; Elmadfa, I; Mitchell, C; Balfour, D; Geleijnse, J M; Manary, M; Nikiema, L; El-kour, T; Mirzaei, M; Hakeem, R
EMBASE:2021228968
ISSN: 2662-1355
CID: 5513812
Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction
Dragioti, Elena; Radua, Joaquim; Solmi, Marco; Gosling, Corentin J; Oliver, Dominic; Lascialfari, Filippo; Ahmed, Muhammad; Cortese, Samuele; Estradé, Andrés; Arrondo, Gonzalo; Gouva, Mary; Fornaro, Michele; Batiridou, Agapi; Dimou, Konstantina; Tsartsalis, Dimitrios; Carvalho, Andre F; Shin, Jae Il; Berk, Michael; Stringhini, Silvia; Correll, Christoph U; Fusar-Poli, Paolo
Empirical evidence indicates a significant bidirectional association between mental disorders and physical diseases, but the prospective impact of men-tal disorders on clinical outcomes of physical diseases has not been comprehensively outlined. In this PRISMA- and COSMOS-E-compliant umbrella review, we searched PubMed, PsycINFO, Embase, and Joanna Briggs Institute Database of Systematic Reviews and Implementation Reports, up to March 15, 2022, to identify systematic reviews with meta-analysis that examined the prospective association between any mental disorder and clinical outcomes of physical diseases. Primary outcomes were disease-specific mortality and all-cause mortality. Secondary outcomes were disease-specific incidence, functioning and/or disability, symptom severity, quality of life, recurrence or progression, major cardiac events, and treatment-related outcomes. Additional inclusion criteria were further applied to primary studies. Random effect models were employed, along with I2 statistic, 95% prediction intervals, small-study effects test, excess significance bias test, and risk of bias (ROBIS) assessment. Associations were classified into five credibility classes of evidence (I to IV and non-significant) according to established criteria, complemented by sensitivity and subgroup analyses to examine the robustness of the main analysis. Statistical analysis was performed using a new package for conducting umbrella reviews (https://metaumbrella.org). Population attributable fraction (PAF) and generalized impact fraction (GIF) were then calculated for class I-III associations. Forty-seven systematic reviews with meta-analysis, encompassing 251 non-overlapping primary studies and reporting 74 associations, were included (68% were at low risk of bias at the ROBIS assessment). Altogether, 43 primary outcomes (disease-specific mortality: n=17; all-cause mortality: n=26) and 31 secondary outcomes were investigated. Although 72% of associations were statistically significant (p<0.05), only two showed convincing (class I) evidence: that between depressive disorders and all-cause mortality in patients with heart failure (hazard ratio, HR=1.44, 95% CI: 1.26-1.65), and that between schizophrenia and cardiovascular mortality in patients with cardiovascular diseases (risk ratio, RR=1.54, 95% CI: 1.36-1.75). Six associations showed highly suggestive (class II) evidence: those between depressive disorders and all-cause mortality in patients with diabetes mellitus (HR=2.84, 95% CI: 2.00-4.03) and with kidney failure (HR=1.41, 95% CI: 1.31-1.51); that between depressive disorders and major cardiac events in patients with myocardial infarction (odds ratio, OR=1.52, 95% CI: 1.36-1.70); that between depressive disorders and dementia in patients with diabetes mellitus (HR=2.11, 95% CI: 1.77-2.52); that between alcohol use disorder and decompensated liver cirrhosis in patients with hepatitis C (RR=3.15, 95% CI: 2.87-3.46); and that between schizophrenia and cancer mortality in patients with cancer (standardized mean ratio, SMR=1.74, 95% CI: 1.41-2.15). Sensitivity/subgroup analyses confirmed these results. The largest PAFs were 30.56% (95% CI: 27.67-33.49) for alcohol use disorder and decompensated liver cirrhosis in patients with hepatitis C, 26.81% (95% CI: 16.61-37.67) for depressive disorders and all-cause mortality in patients with diabetes mellitus, 13.68% (95% CI: 9.87-17.58) for depressive disorders and major cardiac events in patients with myocardial infarction, 11.99% (95% CI: 8.29-15.84) for schizophrenia and cardiovascular mortality in patients with cardiovascular diseases, and 11.59% (95% CI: 9.09-14.14) for depressive disorders and all-cause mortality in patients with kidney failure. The GIFs confirmed the preventive capacity of these associations. This umbrella review demonstrates that mental disorders increase the risk of a poor clinical outcome in several physical diseases. Prevention targeting mental disorders - particularly alcohol use disorders, depressive disorders, and schizophrenia - can reduce the incidence of adverse clinical outcomes in people with physical diseases. These findings can inform clinical practice and trans-speciality preventive approaches cutting across psychiatric and somatic medicine.
PMCID:9840513
PMID: 36640414
ISSN: 1723-8617
CID: 5470482